Takeaway
ADHD in girls and women often looks different—frequently masked by years of compensatory strategies. Recognizing the full spectrum of presentations can expedite the diagnosis so as to more efficiently connect patients with evidence-based treatment.
Lifelong learning in clinical excellence | September 14, 2026 | 4 min read
By Benjamin Young, MD, and Benjamin Young, MD, Wayne State University
After years of unfinished projects and missed appointments and work deadlines, 45-year-old Lisa finally sat across from a clinician and heard the words she’d never expected: she had ADHD. The diagnosis was both a relief and a source of grief for the years that had passed without answers or appropriate support.
ADHD is characterized by a complex mosaic of symptoms with diverse presentations across ages and genders. Women may present differently from the stereotypes built on years of narrow representation in medicine and media. Teachers, parents, and clinicians are often more likely to notice and treat prominent hyperactivity, while inattentive or less disruptive presentations can go unrecognized. As a result, some women seek care only after years of difficulty with attention, organization, emotional regulation, and executive functioning. Healthcare professionals need to recognize ADHD even when patients don’t fit stereotypical expectations.
Where the gender gap starts
The male-to-female ratio of ADHD diagnoses is approximately 4:1 in clinical samples of children, compared with closer to 2:1 in community or population studies. By adulthood, the gap narrows further in many samples. These differences suggest that at least part of the childhood disparity reflects under-recognition and delayed diagnosis in girls. Referral patterns may contribute—children whose symptoms are more disruptive or externally visible are more likely to come to clinical attention, while girls with significant ADHD symptoms may be perceived as having less functional impairment.
Distinct presentations
ADHD diagnostic criteria are standardized, but symptom expression and recognition can differ by context. At the group level, girls are more likely to present with predominantly inattentive symptoms, whereas boys are more often recognized for hyperactive-impulsive or combined presentations. These are tendencies rather than rules, and there’s substantial overlap between sexes. The practical problem is that less externalizing presentations may create a higher barrier to recognition, referral, and treatment.
Masking ADHD doesn’t erase it
Less visible symptoms can be difficult to recognize, particularly when a patient has spent years developing compensatory strategies. Some women describe internal restlessness, mind wandering, time blindness, repeated task switching, or difficulty organizing and following through. They may compensate through rigid routines, extensive use of alarms and schedules, perfectionism, or working unusually long hours to stay ahead of responsibilities. These strategies can make impairment less obvious to observers while requiring substantial cognitive effort and contributing to fatigue or burnout.
High expectations
Social expectations can further shape how impairment becomes visible. Women may face pressure to manage school or career demands while also coordinating family schedules, household logistics, and everyday responsibilities. As demands increase during adolescence and adulthood, compensatory strategies that previously worked may become less effective. This can help explain why some women first seek evaluation during major life transitions, when executive demands begin to exceed their ability to compensate.
When comorbidities obscure ADHD
ADHD commonly co-occurs with anxiety, depression, and other psychiatric conditions, and overlapping symptoms can complicate recognition. Emotional distress may become the initial focus of treatment while underlying attentional and executive-function difficulties remain unrecognized. Research suggests that females with ADHD are more likely than males to have some co-occurring mental health conditions identified before their ADHD diagnosis and may receive non-ADHD medications first. Clinicians should therefore consider both comorbidity and diagnostic overlap rather than assuming that one diagnosis necessarily explains the entire presentation.
Individualized care
Despite differences in symptom presentation and ongoing research into sex-related biological and treatment differences, current frontline ADHD treatment is not based on separate male and female algorithms. Stimulants, including methylphenidate and amphetamine formulations, remain well-established treatments across populations. Evidence-based nonstimulant options, including atomoxetine and guanfacine, may also be appropriate depending on age, comorbidities, treatment response, adverse effects, and patient preference. Treatment should be individualized rather than determined by gender alone.
Key takeaways
1 . ADHD symptoms can change across development and vary substantially between individuals.
2. Girls are more likely, at the group level, to present with less externally visible or predominantly inattentive symptoms, but many patients fall outside stereotypical patterns.
3. The diagnostic gender gap begins early, and underrecognition of girls with significant ADHD symptoms can contribute to delayed diagnosis.
4. Women may first present with anxiety, depression, burnout, or other concerns after years of compensating for underlying ADHD-related difficulties.
5. Recognition of less stereotypical presentations can reduce missed or delayed diagnoses while still applying the same evidence-based diagnostic standards.
With increasing numbers of patients seeking answers, clinicians should recognize the full range of ADHD presentations without replacing one stereotype with another. Careful assessment of symptoms, developmental history, functional impairment, and comorbidities can help reduce delayed or missed diagnoses and connect patients with appropriate, evidence-based treatment.
Read more:
This piece expresses the views solely of the author. It does not necessarily represent the views of any organization, including Johns Hopkins Medicine.